| Product Name |
Linagliptin Inhouse Impurity 9 / Linagliptin Acetamide
|
| Product Category |
Impurities, Intermediates |
| Sub-Category |
Pharmaceutical Standards, Fine Chemicals |
| CAS No |
1803079-49-3 |
| Catalog Number |
GS.33.LNG.39 |
| Chemical Name/Synonyms |
8-[(3R)-3-Acetylamino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione; (R)-N-(1-(7-(But-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)acetamide; |
| Molecular Weight |
514.58000000000004 |
| Molecular Formula |
C27H30N8O3 |
| Purity |
NLT 95 % |
| Appearance |
Light Yellow to Yellow Solid |
| Solubility |
DMSO, Methanol |
| Applications |
Linagliptin Acetamide is an impurity of linagliptin (L465900), which is a novel potent and selective dipeptidyl peptidase-4 inhibitor with potential use in the treatment of type 2 diabetes. |
| Inventory Status |
QC Pending
|
